Rosenberg SA - Search Results

1

An improved method for growing murine tumor-infiltrating lymphocytes with in vivo antitumor activity.

Yang JC, Perry-Lalley D, Rosenberg SA. Yang JC, et al. Among authors: rosenberg sa. J Biol Response Mod. 1990 Apr;9(2):149-59. J Biol Response Mod. 1990. PMID: 1971302

2

Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes.

Friedman KM, Prieto PA, Devillier LE, Gross CA, Yang JC, Wunderlich JR, Rosenberg SA, Dudley ME. Friedman KM, et al. Among authors: rosenberg sa. J Immunother. 2012 Jun;35(5):400-8. doi: 10.1097/CJI.0b013e31825898c5. J Immunother. 2012. PMID: 22576345 Free PMC article.

3

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response.

Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sanders M, Lotze M, Topalian S, Yang J, Rosenberg SA. Aebersold P, et al. Among authors: rosenberg sa. J Natl Cancer Inst. 1991 Jul 3;83(13):932-7. doi: 10.1093/jnci/83.13.932. J Natl Cancer Inst. 1991. PMID: 2067036 Clinical Trial.

4

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, et al. Rosenberg SA, et al. N Engl J Med. 1988 Dec 22;319(25):1676-80. doi: 10.1056/NEJM198812223192527. N Engl J Med. 1988. PMID: 3264384

5

Current approaches to the adoptive immunotherapy of cancer.

Yang JC, Rosenberg SA. Yang JC, et al. Among authors: rosenberg sa. Adv Exp Med Biol. 1988;233:459-67. doi: 10.1007/978-1-4899-5037-6_50. Adv Exp Med Biol. 1988. PMID: 3265581

6

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

Spiess PJ, Yang JC, Rosenberg SA. Spiess PJ, et al. Among authors: rosenberg sa. J Natl Cancer Inst. 1987 Nov;79(5):1067-75. J Natl Cancer Inst. 1987. PMID: 3500355

7

In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.

Hwu P, Yang JC, Cowherd R, Treisman J, Shafer GE, Eshhar Z, Rosenberg SA. Hwu P, et al. Among authors: rosenberg sa. Cancer Res. 1995 Aug 1;55(15):3369-73. Cancer Res. 1995. PMID: 7614473

8

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.

Rosenberg SA, Yannelli JR, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE. Rosenberg SA, et al. J Natl Cancer Inst. 1994 Aug 3;86(15):1159-66. doi: 10.1093/jnci/86.15.1159. J Natl Cancer Inst. 1994. PMID: 8028037

9

The use of interleukin-6 to generate tumor-infiltrating lymphocytes with enhanced in vivo antitumor activity.

Marcus SG, Perry-Lalley D, Mulé JJ, Rosenberg SA, Yang JC. Marcus SG, et al. Among authors: rosenberg sa. J Immunother Emphasis Tumor Immunol. 1994 Feb;15(2):105-12. doi: 10.1097/00002371-199402000-00003. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8136942

10

A tumor-elaborated supernatant factor chemotactic for IL-2 expanded tumor infiltrating T-lymphocytes.

Averbook BJ, Wei JP, Perry-Lalley DM, Rosenberg SA, Yang JC. Averbook BJ, et al. Among authors: rosenberg sa. Lymphokine Cytokine Res. 1993 Feb;12(1):1-8. Lymphokine Cytokine Res. 1993. PMID: 8457627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,359 results

Search Page

Filters